How to Evaluate Investment Risk During Due Diligence

Effective investment decisions depend on more than enthusiasm for a business idea. Risk evaluation is the backbone of any credible due diligence process, and for Swiss and European investors assessing an SME, it means examining both financial substance and operational reality before committing capital. The goal is straightforward: surface the exposures that could erode returns, and determine whether the company has credible plans to address them.

Why Evaluating Investment Risk is Crucial

1. Maximizing Returns

Every investor wants to protect and grow capital. Risk evaluation is not about finding reasons to walk away – it is about understanding the gap between projected returns and realistic outcomes. Identifying risks early lets investors judge whether the potential reward justifies the exposure, or whether the SME has concrete strategies to bring risk down to an acceptable level.

In Swiss fintech, for instance, investors routinely stress-test assumptions against possible regulatory shifts in both Swiss and EU financial markets, since a policy change affecting payment licensing or lending structures can rewrite a growth forecast overnight.

2. Protecting Capital

A thorough risk assessment is what separates informed capital allocation from expensive guesswork. SMEs operating in heavily regulated industries – healthcare, financial services, energy – carry risk profiles that require specific scrutiny. Missing a regulatory trigger or misreading a compliance gap can wipe out significant value quickly.

Consider a Swiss investor looking at a technology company whose path to market depends on a regulatory approval still pending. If approval fails or stalls, the entire market access thesis collapses. That scenario needs to be priced in, not discovered post-close.

Financial Due Diligence Switzerland: What Buyers and Sellers Need to Prepare

Financial due diligence Switzerland is the structured process by which a buyer verifies the financial substance of a target company before completing an acquisition. For Swiss SME transactions – typically in the CHF 2M-50M enterprise value range – the scope covers quality of earnings (QoE) analysis, normalised EBITDA calculation, working capital peg, net debt position, and identification of off-balance-sheet liabilities such as operating leases, pension obligations under Swiss GAAP, and contingent tax exposures. Unlike Anglo-Saxon markets where Big Four firms dominate, the Swiss mid-market relies heavily on specialist advisory firms with deep Swiss accounting knowledge to deliver deal-ready financial due diligence that stands up to scrutiny by buyers and their financing banks.

Sellers who prepare for financial due diligence Switzerland in advance – typically 12-18 months before going to market – achieve meaningfully better outcomes: fewer price adjustments, cleaner completion mechanics, and shorter exclusivity periods that reduce execution risk. The preparation involves normalising historical accounts, resolving related-party transactions at the arm's-length standard, addressing any ESTV open years, and building a vendor due diligence (VDD) report that addresses the questions every credible buyer will ask. The Scalemetrics team has supported both buy-side and sell-side financial due diligence mandates across Swiss SME transactions in M&A, technology, and healthcare, and can advise on the preparation required for your specific exit or acquisition timeline.

Key Types of Investment Risks to Evaluate

1. Market Risk

Market risk is the possibility that broader conditions shift in ways that undercut an SME's growth trajectory. Investors need to look carefully at the company's positioning within its market – who the competitors are, how the target customer behaves, and whether the addressable market is expanding or contracting.

Key factors to examine:

• Market size and realistic growth potential
• Competitor analysis and differentiation
• Customer adoption rates and switching costs

A Swiss cleantech SME entering a growing renewable energy sector carries meaningfully less market risk than one attempting to carve out share in a declining niche. The direction of the market matters as much as the company's position within it.

2. Financial Risk

Financial health analysis sits at the centre of any due diligence. Investors need to understand not just whether a company is profitable, but whether it generates sufficient cash to fund operations – and what the trajectory looks like under stress. An SME with solid gross margins but chronic cash flow shortfalls is a financial risk, even if the income statement looks clean.

Key financial metrics:

• Cash flow statements (operating, investing, financing)
• Profitability ratios (gross margin, EBITDA margin)
• Burn rate and remaining runway

A Swiss biotech SME consuming cash ahead of revenue generation presents real financial risk if its next funding round is not secured before the runway closes. Investors need to know the timeline, the plan, and the fallback.

3. Regulatory and Legal Risk

Regulated sectors require dedicated attention to the compliance landscape. In fintech, healthcare, and energy, regulatory requirements shape what a company can do, how it can price its products, and whether it can enter certain markets at all. Changes to legislation – in Switzerland or the EU – can invalidate assumptions baked into a financial model.

Key areas to assess:

• Current regulatory compliance status
• Pending legislation or policy consultations that could affect operations
• Intellectual property protections (patents, trademarks, trade secrets)

Swiss SMEs expanding into the EU face the additional complexity of GDPR compliance, medical device regulations, and jurisdiction-specific licensing requirements. Each layer adds execution risk that investors must factor into their assessment.

4. Operational Risk

Operational risk covers the internal factors that could disrupt a business: supply chain fragility, team capability gaps, technology infrastructure failures, or an over-reliance on a small number of key personnel. An SME that cannot scale its operations without proportionally increasing its cost base, or that depends on a single supplier for a critical input, carries operational risk that may not be visible in the financials alone.

Key operational aspects to assess:

• Supply chain concentration and alternative sourcing
• Team structure, depth, and key-person dependencies
• Technology reliability and infrastructure resilience

A Swiss retail SME sourcing heavily from international suppliers faces real disruption risk if trade conditions change or shipping lanes are affected. Diversification of supply is a mitigation investors should actively look for.

5. Technology and Innovation Risk

SMEs built around new technology face a specific class of risk: the technology may not perform as expected, development may take longer than planned, or a competing solution may reach market first. Investors need to assess the technical feasibility of the product, the credibility of the development roadmap, and the strength of any IP protection.

Key factors:

• Technical feasibility and current development stage
• Realistic product development timelines
• Patent coverage and IP ownership clarity

A Swiss AI SME whose technology lacks scalability, or whose core algorithm is not protected, faces compounding risk if a well-funded competitor launches a comparable solution before the company has established its market position.

Red Flags in Investment Risk Evaluation

1. Overly Optimistic Projections

Financial projections that show hockey-stick growth without a credible underlying logic are a warning sign. The assumptions behind revenue forecasts – customer acquisition rates, average contract values, churn – need to be tested against comparable companies and actual market data. If an SME cannot explain its growth assumptions at a granular level, investors should treat the projections with caution.

A practical approach: use third-party market reports and independent benchmarks to pressure-test the numbers the SME has provided. Projections that cannot survive that comparison need revision before investment.

2. Lack of Financial Transparency

Incomplete financial statements, unexplained line items, or inconsistencies across different documents all signal potential problems. Transparent financial reporting is a baseline expectation, not a premium. If the company cannot or will not provide clear accounts, that reluctance raises legitimate questions about what is being obscured.

If documents are missing or access is restricted, treat it as a prompt to investigate further, not a minor administrative issue.

3. Over-Reliance on One Market or Client

An SME that derives the majority of its revenue from a single client or operates in a single geography carries concentration risk that directly threatens financial stability. Losing one major customer can eliminate a substantial share of revenue overnight. Investors should review the client distribution carefully and ask directly about contract terms, renewal histories, and client retention rates.

Revenue diversification across clients, products, and geographies reduces this exposure. SMEs that have already begun that diversification are demonstrably lower risk.

How to Mitigate Investment Risk

1. Conduct Thorough Market Research

The SME's own data is a starting point, not the full picture. Investors should commission or conduct independent market research to verify the assumptions behind the business plan. That means looking at broader sector trends, actual customer demand signals, and the competitive landscape as it exists today – not as the company has characterised it.

Use third-party industry reports and data from sources like Swiss National Bank (SNB) publications, sector associations, and comparable transaction data to cross-check what the SME is claiming.

2. Implement Risk Mitigation Strategies

Due diligence is also a negotiation. Investors and management can use the process to build out concrete mitigation plans for the risks identified. Contingency plans for supply chain disruptions, diversification roadmaps for over-concentrated revenue, and compliance roadmaps for pending regulatory changes are all legitimate outputs of a well-run diligence process.

A Swiss fintech SME facing anti-money laundering (AML) compliance obligations, for example, should enter the investment conversation with a documented compliance programme – not a vague intention to address the issue post-close.

3. Focus on Scalability

An SME that can grow its revenue without a proportional increase in cost and risk is a fundamentally better investment than one where growth and operational complexity scale together. Investors should probe the business model directly: what happens to margins at 2x revenue? What infrastructure, headcount, or capital expenditure does that require? A company that can scale its platform internationally without significantly increasing its operational cost base demonstrates a risk profile that supports a higher valuation.

Case Study: Evaluating Risk in a Swiss SME Investment

A Swiss-based medtech SME was seeking investment to scale its operations and expand into the EU. During due diligence, investors identified several key risks: regulatory challenges related to medical device approvals in different EU countries, a heavy reliance on one supplier for critical components, and optimistic revenue projections based on limited clinical trial data. To mitigate these risks, the investors worked with the SME to develop a regulatory strategy, diversify its supplier base, and revise its financial projections to reflect more conservative growth.

The outcome was a cleaner deal structure, better-aligned expectations, and a company that entered its growth phase with the operational foundations to support it.

Conclusion: A Structured Approach to Evaluating Investment Risk

Evaluating investment risk during due diligence protects capital and produces better investment decisions. By examining market, financial, operational, regulatory, and technological risks with discipline, investors can move from a surface-level read of a business to a substantive understanding of its risk-adjusted return potential.

For Swiss investors and lenders, the emphasis should sit on scalability, financial transparency, and market dynamics – across both the Swiss domestic market and any international expansion. SMEs that arrive at the due diligence table with clear risk documentation and credible mitigation strategies are more likely to close investment on favourable terms.

Scalemetrics helps Swiss SMEs prepare for exactly this conversation. Our financial due diligence services and outsourced CFO team give finance directors the senior expertise to move first.

Frequently Asked Questions

Why does evaluating investment risk help investors decide whether a company is fundable?

Investors are always looking to maximize their returns, and evaluating risks helps them understand the potential for losses. By identifying risks early, investors can determine whether the potential reward is worth the investment or whether the SME has strategies in place to mitigate these risks.

What does market risk assessment cover during investment due diligence?

Market risk refers to the possibility that changes in the broader market will negatively impact the SME's growth potential. Investors should evaluate the SME's market dynamics, including its positioning, competition, and target audience. Understanding whether the market is saturated or ripe for disruption is critical to evaluating risk.

Why are unsupported financial projections a red flag during investment due diligence?

If an SME presents overly optimistic financial projections without evidence to back them up, this could be a red flag. Investors should cross-check the assumptions behind the growth projections and assess whether they are realistic given the current market conditions.

How should investors conduct their own market research to assess investment risk?

Investors should conduct their own market research beyond the SME's provided data. Understanding the broader market trends, customer demand, and competitive landscape will help assess the risk associated with market entry or expansion.

What risks did investors identify in a Swiss medtech company before its EU expansion?

A Swiss-based medtech SME was seeking investment to scale its operations and expand into the EU. During due diligence, investors identified several key risks: regulatory challenges related to medical device approvals in different EU countries, a heavy reliance on one supplier for critical components, and optimistic revenue projections based on limited clinical trial data. To mitigate these risks, the investors worked with the SME to develop a regulatory strategy, diversify its supplier base, and revise its financial projections to reflect more conservative growth.

What financial documents do Swiss investors and banks require?

Swiss investors and banks typically require three years of OR-compliant financial statements, a 3-5 year financial model, a 13-week cash flow forecast, a cap table, and KPI dashboards. Series A investors additionally expect audited accounts and unit economics. The Scalemetrics team prepares investor-grade financial packages for Swiss SMEs.

How does a fractional CFO help Swiss SMEs raise financing?

A fractional CFO improves Swiss SME financing outcomes by building the financial model, preparing OR-compliant statements, structuring the data room, and presenting financials credibly to banks or investors. SMEs with a proper finance function secure better terms and faster credit decisions. The Scalemetrics team supports the full financing process from initial model to term sheet.